Enhanced circulating soluble LR11 in patients with diabetic retinopathy

American Journal of Ophthalmology

Volumn 154, Issue 1, 2012, Pages 187-192

  Takahashi, Mao ^a   Bujo, Hideaki ^b   Shiba, Tomoaki ^a   Jiang, Meizi ^b   Maeno, Takatoshi ^a   Shirai, Kohji ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN RECEPTOR; LR11; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNODETECTION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LUMINESCENT MEASUREMENTS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; RISK FACTORS; ROC CURVE;

EID: 84862774224     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.01.035     Document Type: Article

References (23)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54(6):1615-1625. (Pubitemid 40770750)
2. Bujo H, Saito Y. Modulation of smooth muscle cell migration by members of the low-density lipoprotein receptor family. Arterioscler Thromb Vasc Biol 2006;26(6):1246-1252. (Pubitemid 44313583)
3. Ting HJ, Stice JP, Schaff UY, et al. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res 2007;100(3):381-390.
4. Takahashi M, Bujo H, Jiang M, et al. Enhanced circulating soluble LR11 in patients with coronary organic stenosis. Atherosclerosis 2010;210(2):581-584.
5. Jiang M, Bujo H, Ohwaki K, Noike H, Saito Y, Shirai K. AngII-stimulated migration of vascular SMC is dependent on LR11. J Clin Invest 2008;118(8):2733-2746.
6. Henricsson M, Nilsson A, Heijl A, Heijl A, Janzon L, Groop L. Mortality in diabetic patients participating in an ophthalmological control and screening programme. Diabet Med 1997;14(7):576-583. (Pubitemid 27298818)
7. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999;117(11):1487-1495. (Pubitemid 29536476)
8. Rajala U, Koskela P, Pajumppaa H, Keinanen-Kiukaannieemi S. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 2000;23(7):957-961. (Pubitemid 30480023)
9. Sundell J, Janatuinen T, Ronnemaaa T, et al. Diabetic background retinopathy is associated with impaired coronary vasoreactivity on people with type 1 diabetes. Diabetologia 2004;47(4):725-731. (Pubitemid 38658375)
10. Ohno T, Takamoto S, Motomura N, et al. Coronary artery by-pass grafting versus coronary implantation of sirolimus-eluting stents in patients with diabetic retinopathy. Ann Thorax Surg 2007;84(5):1474 -1478.
11. Ohno T, Takamoto S, Motomura N. Diabetic retinopathy and coronary artery disease from the cardiac surgeon's perspective. Ann Thorax Surg 2008;85(2):681-689.
12. Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110(9):1677-1682. (Pubitemid 37025422)
13. Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007;11(1):41-50. (Pubitemid 46474965)
14. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331(22):1480-1487. (Pubitemid 24356306)
15. Castellon R, Hamdi HK, Sacerio I, Aoki AM, Kenney MC, Ljubimov AV. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res 2002;74(4):523-535. (Pubitemid 34757030)
16. Wilkinson-Berka JL. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 2006;38(5-6):752-765. (Pubitemid 43372053)
17. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995;147(3):642-653.
18. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009;94(9):3171-3182.
19. Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009;32(10):1901-1903.
20. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9139):837-853.
21. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus. A randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28(2):103-117.
22. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116(3):297-303.
23. El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. Retinopathy as a predictor of other diabetic complications. Int Ophthalmol 2001;24(1):1-11.